Upgrade to SI Premium - Free Trial

Viking Therapeutics (VKTX) Tops Q3 EPS by 2c

October 23, 2024 4:15 PM

Viking Therapeutics (NASDAQ: VKTX) reported Q3 EPS of ($0.22), $0.02 better than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

Categories

Earnings

Next Articles